12,145 followers
RT @FrontOncology: New research: SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophy…
RT @FrontOncology: New research: SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophy…
New research: SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study: From 8 December 2021 to 26 January 2023, tixagevimab–cilgavimab (T-C) was… #oncology https:/